P
Power Law company profile
Penumbra
Biotech & Life Sciences · Alameda, United States · Founded 2004 · IPO 2015 Decacorn
Valuation
$12B
Market cap · Apr/2026
Revenue
$1.40B
Latest reported FY
Global footprint
Where Penumbra has talent and traffic
AI talent share
0.2%
of workforce is AI talent
(5 of 3,076 staff)
(5 of 3,076 staff)
Core AI00%
Other AI50.16%
Non-AI workforce3,07199.84%
Web traffic by country
62K
monthly visits
across markets
across markets
🇺🇸 United States44.4%
🏳️ Korea8.2%
🏳️ Republic of7.9%
🇦🇺 Australia6.5%
🇨🇦 Canada4.4%
Patent intelligence
$22M patent portfolio · 48 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$22M
0.17% of market cap · 23.3× smaller than top peer Insulet ($502M)
48 active patent families
Where Penumbra innovates
Virtual realityPhysical medicine and rehabilitationVirtual worldNeurorehabilitationTreatment seeking
Above peer median on Legal, Economic
Quality vs same-sector peers
Penumbra on the five Patsnap quality dimensions
Penumbra in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Penumbra concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Penumbra and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Penumbra on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.